BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27037389)

  • 1. HIV-indicator-condition-driven HIV testing: clinically effective but still rarely implemented.
    Bull L; Rayment M
    Clin Med (Lond); 2016 Apr; 16(2):175-9. PubMed ID: 27037389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The late-presenting HIV-infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis.
    Tominski D; Katchanov J; Driesch D; Daley MB; Liedtke A; Schneider A; Slevogt H; Arastéh K; Stocker H
    HIV Med; 2017 Feb; 18(2):125-132. PubMed ID: 27478058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis?
    Lin YD; Garner SE; Lau JSY; Korman TM; Woolley IJ
    QJM; 2019 Jan; 112(1):17-21. PubMed ID: 30295832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting HIV indicator condition-guided testing in hospital settings (PROTEST 2.0): study protocol for a multicentre interventional study.
    Bogers SJ; Schim van der Loeff MF; Davidovich U; Boyd A; van der Valk M; Brinkman K; de Bree GJ; Reiss P; van Bergen JEAM; Geerlings SE;
    BMC Infect Dis; 2021 Jun; 21(1):519. PubMed ID: 34078315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV testing in patients presenting with indicator conditions in outpatient settings: offer and uptake rates, and educational and active interventions.
    Youssef E; Sanghera T; Bexley A; Hayes M; Perry N; Dosekun O; Perera S
    Int J STD AIDS; 2018 Nov; 29(13):1289-1294. PubMed ID: 29979144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Towards zero new HIV infections in the Netherlands: proactive testing in case of indicator conditions].
    Bogers SJ; Jordans CCE; Rokx C
    Ned Tijdschr Geneeskd; 2021 Nov; 165():. PubMed ID: 35138722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study).
    Sullivan AK; Raben D; Reekie J; Rayment M; Mocroft A; Esser S; Leon A; Begovac J; Brinkman K; Zangerle R; Grzeszczuk A; Vassilenko A; Hadziosmanovic V; Krasnov M; Sönnerborg A; Clumeck N; Gatell J; Gazzard B; Monforte Ad; Rockstroh J; Lundgren JD
    PLoS One; 2013; 8(1):e52845. PubMed ID: 23341910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An audit of HIV testing practice in people aged 50 years and over presenting with a known clinical indicator condition in secondary care.
    Gill RC; Levett T; Youssef E
    HIV Med; 2023 Feb; 24(2):231-235. PubMed ID: 35811462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, characteristics and challenges of late HIV diagnosis in Germany: an expert narrative review.
    Boesecke C; Schellberg S; Schneider J; Schuettfort G; Stocker H
    Infection; 2023 Oct; 51(5):1223-1239. PubMed ID: 37470977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of skin disease in patients infected with human immunodeficiency virus in Bangkok, Thailand.
    Sivayathorn A; Srihra B; Leesanguankul W
    Ann Acad Med Singap; 1995 Jul; 24(4):528-33. PubMed ID: 8849182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better.
    Darling KE; Hachfeld A; Cavassini M; Kirk O; Furrer H; Wandeler G
    Swiss Med Wkly; 2016; 146():w14348. PubMed ID: 27544642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking missed opportunities for an early HIV diagnosis in a population of people living with HIV with known time of infection.
    Basoulis D; Kostaki EG; Paraskevis D; Hatzakis A; Psichogiou M
    Sex Transm Infect; 2022 Mar; 98(2):79-84. PubMed ID: 33608478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vital signs: HIV testing and diagnosis among adults--United States, 2001-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Dec; 59(47):1550-5. PubMed ID: 21124295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis.
    Scognamiglio P; Chiaradia G; De Carli G; Giuliani M; Mastroianni CM; Aviani Barbacci S; Buonomini AR; Grisetti S; Sampaolesi A; Corpolongo A; Orchi N; Puro V; Ippolito G; Girardi E;
    BMC Infect Dis; 2013 Oct; 13():473. PubMed ID: 24112129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions.
    Lord E; Stockdale AJ; Malek R; Rae C; Sperle I; Raben D; Freedman A; Churchill D; Lundgren J; Sullivan AK;
    HIV Med; 2017 Apr; 18(4):300-304. PubMed ID: 27535357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid STTR intervention for heterosexuals using anonymous HIV testing and confidential linkage to care: a single arm exploratory trial using respondent-driven sampling.
    Gwadz M; Cleland CM; Leonard NR; Kutnick A; Ritchie AS; Banfield A; Hagan H; Perlman DC; McCright-Gill T; Sherpa D; Martinez BY;
    BMC Public Health; 2015 Nov; 15():1133. PubMed ID: 26572865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for indicator condition-guided HIV screening.
    Lazarus JV; Hoekstra M; Raben D; Delpech V; Coenen T; Lundgren JD;
    HIV Med; 2013 Aug; 14(7):445-8. PubMed ID: 23480600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
    Lohse N
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836803
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.